| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |